C3.ai is in a damaged longer-term downtrend that is only now attempting to base. The stock is down 37.32% over the trailing year and 17.67% year-to-date, a stark underperformance versus the S&P 500's +15.53% one-year and +11.93% YTD returns, producing a relative strength of -52.85 over twelve months. At $11.32, the shares sit roughly 31.5% above the 52-week low of $7.675 and about 39.8% below the 52-week high of $18.79, placing the price at approximately 32.8% of its 52-week range — closer to the floor than the ceiling, which is characteristic of a broken momentum name rather than an extended one. The maximum drawdown of -60.53% underscores how violent the de-rating has been and argues for treating rallies as suspect until proven otherwise.

Short-term momentum, however, has turned decisively positive and is diverging from the one-year trend. The stock is up 28.34% over three months, 22.51% over six months, and 7.20% over the past month, versus a 1.22% one-month and 2.69% three-month gain for SPY, yielding relative strength of +5.98 (1M), +25.65 (3M), and +15.03 (6M). This is a classic mean-reversion rally off a washed-out base rather than confirmation of a new uptrend, and the most recent session is a warning: the stock fell 6.91% on the day from a $12.16 close to $11.32, on elevated volume of roughly 9.7 million shares. That sharp reversal near the top of the recent range suggests supply is still present on strength, and the divergence between a -37.32% one-year return and a +28.34% three-month return signals a bottoming attempt that has not yet been validated.

Key technical levels are well defined. Support sits at the 52-week low of $7.675, with the recent consolidation zone around $8.15–$8.90 acting as secondary support; a breakdown below $7.675 would confirm the downtrend and likely trigger another leg lower. Resistance is the 52-week high of $18.79, but the more immediate battleground is the $12.00–$12.16 area where the stock just failed — a clean breakout above that zone would signal the rally has legs, while repeated rejection keeps the stock range-bound. With a beta of 2.095, the shares are roughly 110% more volatile than the market, meaning position sizing should be materially smaller than a market-beta equivalent and stops should be wider to avoid noise-driven exits.

The revenue trajectory is deteriorating, not merely decelerating. Most recent quarterly revenue was $52.375 million, down 25.46% year-over-year, and the multi-quarter trend is unambiguous: revenue fell from $75.147 million in the October 2025 quarter to $53.26 million, $51.60 million, and $52.375 million across the following three quarters, while the year-ago comparable quarter was $70.261 million. The segment disclosure shows only small service lines — Professional Services at $3.206 million, Engineering Services at $1.76 million, and Service Fees at $1.446 million — implying the vast majority of revenue is subscription/platform, so the contraction is in the core business rather than a mix shift. A 25% decline in a company marketed as an enterprise AI pure-play, in the middle of an AI capex boom, is the single most damaging data point in the investment case and suggests competitive displacement rather than macro softness.

The company is deeply unprofitable and the losses are large relative to revenue. The most recent quarter produced a net loss of $92.812 million on $52.375 million of revenue — a net margin of -177.2% — with gross margin of 31.83% ($16.669 million of gross profit) and an operating loss of $98.268 million (operating margin -187.6%). Gross margin has compressed sharply from 62.09% in the April 2025 quarter and 40.43% in October 2025 to 31.83% today, a deterioration that points to pricing pressure and/or a less favorable revenue mix, and it is far below the 70%+ gross margins typical of mature enterprise SaaS. The loss is being driven by operating expenses of $114.937 million against gross profit of only $16.669 million, with R&D at $46.549 million and sales and marketing at $41.611 million — spending that is not being converted into revenue.

Balance-sheet strength is the one genuinely favorable pillar. Debt-to-equity is just 0.0085, the current ratio is 6.64, and cash at the end of the most recent quarter was $149.001 million, so there is no near-term solvency risk. But cash generation is poor: trailing-twelve-month free cash flow is -$154.334 million, and the most recent quarter's positive $2.064 million of FCF was flattered by a $34.67 million working-capital inflow and $59.233 million of stock-based compensation added back, while the prior quarter burned $53.32 million of FCF. ROE of -71.95% and ROA of -31.22% confirm that capital is being destroyed, and with a price-to-free-cash-flow ratio of -6.57 and a cash-flow-to-debt ratio that has swung negative, the company is funding losses from its cash pile and equity issuance ($72.812 million of common stock issued in the latest quarter) rather than from operations.